ASP Isotopes (ASPI) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2024 Annual Meeting will be held virtually on November 20, 2024, with full participation rights for shareholders, including voting and Q&A via webcast.
Shareholders will vote on electing two Class II directors, approving the Quantum Leap Energy LLC 2024 Equity Incentive Plan (as amended), and ratifying EisnerAmper LLP as the independent auditor for 2024.
The record date for voting eligibility is September 23, 2024, with 68,409,116 shares outstanding.
Voting matters and shareholder proposals
Proposal 1: Election of Michael Gorley, Ph.D. and Duncan Moore, Ph.D. as Class II directors for three-year terms expiring in 2027.
Proposal 2: Approval of the Quantum Leap Energy LLC 2024 Equity Incentive Plan, designed to incentivize employees and service providers of the subsidiary, with a maximum of 15% of QLE's common equity authorized for issuance.
Proposal 3: Ratification of EisnerAmper LLP as independent registered public accounting firm for 2024.
Board recommends voting FOR all proposals.
Board of directors and corporate governance
Board consists of six members, four of whom are independent under Nasdaq standards.
Directors are divided into three classes with staggered three-year terms.
Committees include audit, compensation, nominating and corporate governance, and a special projects committee.
Board leadership is unified under Chair and CEO Paul Mann, with regular review of governance practices.
Board and committee charters, as well as the code of business conduct and ethics, are available on the company website.
Latest events from ASP Isotopes
- Helium and isotope production ramp up amid global shortages, with major commercialization by 2026.ASPI
2nd Annual CG Virtual Sustainability Summit12 Mar 2026 - Expansion in isotopes, new contracts, and regulatory progress set up strong 2024 growth.ASPI
Emerging Growth Virtual Conference25 Feb 2026 - Pursuing global leadership in isotope supply with advanced enrichment tech and strategic expansion.ASPI
Corporate presentation4 Feb 2026 - Ytterbium-176 enrichment achieved; strong cash, plant ramp-up, and growth in isotope demand.ASPI
Q4 20244 Feb 2026 - Expanding isotope production, securing major contracts, and advancing HALEU for nuclear energy.ASPI
Emerging Growth Conference7711 Jan 2026 - Isotope enrichment firm seeks up to $100M in flexible offerings, with $25M at-the-market via Canaccord.ASPI
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify auditor, and highlight governance and compensation.ASPI
Proxy Filing25 Nov 2025 - Silicon-28 shipment, JSE listing, and Fermi MOU mark key advances in isotope and energy markets.ASPI
Status Update23 Nov 2025 - Q3 2025 delivered strong revenue growth, major contracts, and strategic expansion moves.ASPI
Q3 202521 Nov 2025